1.Effect of theasinesin on proliferation and apoptosis of murine lymphocytes1
Xiaoyan SHI ; Huawen XIN ; Bijun XIE ; Fandian ZENG
Chinese Journal of Clinical Pharmacology and Therapeutics 2000;0(02):-
AIM: To study the effects of theasinesin(TS) on proliferation and apoptosis of murine lymphocytes. METHODS: MTT method was employed to investigate the proliferatory response of murine splenocytes. Cellular morphological observation, DNA agarose gel electrophoresis and flow cytometry analysis were used to study the effects of TS on apoptosis of murine thymocyte and splenocyte. RESULTS: 50,150 and 500 mg?L -1 TS could markedly promote ConA-induced splenocyte proliferation in mice. In the cellular morphologic observation and DNA biochemical analysis, murine thymocytes cultured for 20 h in vitro showed keryopyk-nosis, condensation of cell, typical "ladder" on gel electrophoresis and typical apoptotic peak (AP) by FACS analysis. After treatment with 50, 150 and 500 mg?L -1 TS , DNA ladder and apoptotic peak were decreased gradually and apoptotic rates were reduced to 12.14%, 9.49%, 6.71% respectively from 19.87% in control group. But the apoptosis of murine splenocytes induced by 10 -5 mol?L -1 DEX was not affected by TS. CONCLUSION: TS can significantly promote splenocyte proliferation in mice and has an inhibitory effect on spontaneous apoptosis of murine thymocytes.
2.The Antitumor Activity and Immunomodulatory Effects of Theasinesin
Huawen XIN ; Xianyan SHI ; Fandian ZENG ; Bijun XIE
China Pharmacy 2001;12(4):204-206
OBJECTIVE:To study the antitumor activity and immunomodulatory effects of theasinesin on mice transplanted tumor and tumor-bearing mice.METHODS: With three mice transplanted tumor models i.e. Ehrlich ascites tumor, sarcoma 180 and hepatic carcinoma H22,we strdied the antitumor activity of theasinesin .The immunomodulatory effects of theasinesin on S180-bearing mice were measured by delayed type hypersensitivity(DTH), cleaning charcoal particles method, and splenocyte proliferation test .RESULTS: Theasinesin at doses of 400,200, 50mg/kg could markedly inhibite the growth of Ehrlich ascites tumor(solid tumor) .Although theasinesin didn't have significant inhibitory effects on sarcoma 180 and hepatic carcinoma H22 in routine oral administration, the average inhibitory rates of each group, in manner of preventive administration, were all greater than 30% .Theasinesin at doses of 50,100,200mg/kg could significantly restore the decreased DTH in S180-bearing mice. It could also markedly increase K, a and promote proliferation of activated T cells in S180- bearing mice. CONCLUSION :Theasinesin has significant inhibitory effects on mice transplanted tumors. It can also enhance the decreased immunological function on tumor-bearing mice.
3.Immunomodulatory effects of theasinesin on human peripheral blood mononuclear cells in vitro
Xiaoyan SHI ; Huawen XIN ; Bijun XIE ; Fandian ZENG ;
Chinese Traditional and Herbal Drugs 1994;0(05):-
Object To study the immunomodulatory effects of theasinesin (TS) on human peripheral blood mononuclear cells (PBMC) in vitro. Methods The proliferation response of lymphocytes and IL 2 production of human PBMC were detected by MTT method. IL 2R expression was determined by immunocytochemistry and indirect immunofluorescence. The intracellular cAMP level was assayed by radioimmunoassay. Results 50, 150, 500 ?g/mL TS could enhance phytagglutinin (PHA) induced human PBMC proliferation in a dose dependent manner. The IL 2 production and IL 2R expression of PHA activated PBMC were increased markedly under the presence of TS. TS also decreased cAMP level of PBMC and intensively weaken the cAMP upregulating effect of prostaglandin E 1 (PGE 1). Conclusion TS possesses a potential immunoenhancing effect which might be made by decreasing the cAMP level of PBMC, promoting IL 2 production and IL 2R expression.
4.Health risk assessment of drinking water in Ningbo City
ZHAO Xuefei ; WANG Aihong ; SHI Bijun ; GU Shaohua ; ZHANG Dandan
Journal of Preventive Medicine 2024;36(4):333-337
Objective:
To evaluate the health risk of drinking water in Ningbo City, Zhejiang Province from 2021 to 2022, so as to provide insights into ensuring the safety of drinking water.
Methods:
The monitoring data of drinking water from 2021 to 2022 in Ningbo City were collected from the Chinese Disease Prevention and Control Information System. The routine indicators and disinfectant indicators (radioactivity indicators were excluded) of drinking water were evaluated according to the reference limits issued by Standards for Drinking Water Quality (GB 5749-2006), and the qualification rates were calculated. The indicators with detection rate higher than 50% were selected, and assessed the carcinogenic and non-carcinogenic risks via drinking water using the risk assessment model recommended by the United States Environmental Protection Agency.
Results:
A total of 1 678 samples were monitored in Ningbo City from 2021 to 2022. Sodium hypochlorite was the main disinfectant among 1 558 samples from centralized water supply (1 079 samples, 64.30%), and none of the 120 samples from decentralized water supply underwent disinfection treatment. The qualification rate of 88.38%, and the pollutants with a detection rate higher than 50% were nitrate, fluoride, trichloromethane and aluminum. The median carcinogenic risk value of trichloromethane was 2.964×10-6 (interquartile range, 3.909×10-6), and the median hazard quotient values of nitrate, fluoride, trichloromethane and aluminum were 1.631×10-2 (interquartile range, 1.361×10-2), 3.955×10-2 (3.164×10-2), 2.231×10-2 (2.942×10-2) and 2.136×10-4 (6.573×10-4), respectively.
Conclusion
The carcinogenic and non-carcinogenic risks through drinking water for 17 pollutants in drinking water of Ningbo City from 2021 to 2022 were at low levels.
5.Effects of hypertensive disorders of pregnancy on birth weight differences in twins
Qiaoyan LUO ; Zhihong ZHONG ; Bijun SHI ; Huang WU ; Xinqi ZHONG ; Qiliang CUI
Chinese Journal of Neonatology 2021;36(6):38-42
Objective:To study the effects of hypertensive disorders of pregnancy (HDP) on the birth weight (BW) differences in twins.Method:From January 2011 to January 2020, twins delivered in our hospital were retrospectively analyzed. The twins born to HDP mothers were the HDP group and those born to healthy mothers were the control group. The maternal and neonatal data of the two groups were collected and the effects of HDP on the BW differences were analyzed.Result:The age of the mothers, the proportion of mothers of older ages and more-than-once delivery in HDP group (418 cases) were significantly higher than the control group (499 cases) [(31.4±5.3) years vs. (30.4±3.8) years, 26.6% (111/418) vs. 12.6% (63/499), 20.6% (86/418) vs. (15.0% (75/499)] ( P<0.05). The gestational age (GA) of newborns in the HDP group (836 cases) was significantly lower than the control group (998 cases) [(35.1±2.2) weeks vs. (36.7±1.2)]( P<0.05). The proportion of twins with GA <34 weeks in the HDP groups was significantly higher than the control group [24.2% (101/418) vs. 3.8% (19/499)] ( P<0.05). Cesarean section was the main delivery mode in both groups. The BW differences of the twins in the HDP group were larger than the control group [22.4% (9.1%, 31.9%) vs. 13.1% (5.8%, 19.6%)]. Significantly more twins in the HDP group showed ≥30% BW difference than the control group [28.7% (120/418) vs. 3.8% (19/499)] ( P<0.05). The incidences of BW discordant in twins (BWDT) in the HDP group was significantly higher than the control group [BWDT≥15%:61.5% (257/418) vs. 38.3% (191/499), BWDT≥20%: 51.4% (215/418) vs. 25.3% (126/499)] ( P<0.05).Among twins with GA of 34~37 weeks, the BW of the bigger infants and the smaller infants in the HDP group were all lower than the control group and the percentage of BW difference was significantly higher than the control group ( P<0.05). Conclusion:HDP may influence the intrauterine growth of the twins, aggravate the BW differences and increase the incidences of BWDT. It is necessary to make better prenatal management of HDP and closely monitor the intrauterine growth of the fetuses.
6.Reliability and validity of Adaptive Behavior Scale for Children with Autism Spectrum Disorder
Chinese Journal of School Health 2020;41(9):1325-1330
Objective:
To develop a native adaptive behavior scale for children with autism spectrum disorder(ASD) and to explore its reliability and validity.
Methods:
Items of ASD adaptive behavior rating scale were selected based on the scale development theory, ASD knowledge and adaptive behavior concept through preliminary survey and statistical, and 301 ASD children aged 2 to 12 from hospitals in Guangzhou, Huizhou, Shenzhen who met the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition were selected, data was analyzed by the item analysis.
Results:
After item analysis and exploratory factor analysis, the final version of the scale contains 58 items, and 64.24% of the total variation could be explained by 6 factors; The Cronbach’s α coefficient of the full scale was 0.98, and the coefficient value of dimen sional factors were 0.94,0.93,0.91,0.95,0.88,0.94. The test-test reliability r of full scale was 0.86, the r of the factor were 0.88,0.81,0.81,0.87,0.88,0.79. The criterion-related validity r with the ABAS-Ⅱ scale was -0.77, the criterion-related validity r with the CARS scale was 0.64.
Conclusion
The ASD Child Adaptive Behavior Scale showed good reliability and validity, and could be used widely.
7.A retrospective analysis of complications during hospitalization in twins with birth weight discordance
Xue LI ; Xiaohua TAN ; Bijun SHI ; Qian CHEN ; Yong ZHANG ; Zhen PAN ; Zicong CAI ; Chunhong JIA ; Qiliang CUI
Chinese Journal of Neonatology 2023;38(11):655-659
Objective:To study the incidences of complications in twins with birth weight discordance (BWD) during hospitalization.Methods:From January 2011 to December 2020, twins born in the Department of Obstetrics and hospitalized in NICU of our hospital were retrospectively studied. Twins with BWD>15% were assigned into BWDT group and BWD≤15% into twins with birth weight concordant (BWCT) group. Complications during hospitalization were compared between the two groups.Results:A total of 1 546 pairs of twins were enrolled, including 486 (31.4%) in BWDT group and 1 060 (68.6%) in BWCT group. Compared with BWCT group, BWDT group had significantly higher incidences of pulmonary surfactant (PS) utilization (47.7% vs. 42.2%), continuous positive airway pressure ≥ 24 h (40.5% vs. 35.0%), high-flow nasal cannula ≥ 24 h (22.8% vs. 16.3%), neonatal respiratory distress syndrome (52.9% vs. 47.1%), bronchopulmonary dysplasia (BPD) (15.6% vs. 11.1%), persistent pulmonary hypertension of the newborn (3.1% vs. 1.4%) and anemia (79.6% vs. 70.1%) (all P<0.05). After adjusting for confounding factors, the risks of pulmonary hemorrhage ( OR=2.036, 95% CI 1.119-3.703, P=0.020) and BPD ( OR=2.960, 95% CI 1.656-5.219, P=0.010) in BWDT group were higher than BWCT group. Conclusions:BWD twins has higher incidences of complications during hospitalization than BWC twins.